Results 201 to 210 of about 40,111 (286)

What is your diagnosis? Abnormal cluster on the WDF and WNR scattergrams from Sysmex XN‐V in a dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Theo Chenal   +3 more
wiley   +1 more source

Nature Knows Best: Extracellular Matrix‐Gelatin Hydrogel Masking Bioauthentic Bone Scaffold Locking Blood Clot to Induce M2 Macrophage‐Mediated Bone Regeneration via Activating an Endocytosis‐Macroautophagy‐Inflammation Axis

open access: yesSmall Structures, Volume 6, Issue 5, May 2025.
Based on individualized design for critical bone defect, biological bone is cut by subtractive manufacturing, sintered into biological hydroxyapatite (BHA) scaffolds, and masked with extracellular matrix‐gelatin hydrogel (ECM‐gel) to prepare gelatin hydrogel‐masked BHA (G‐BHA) scaffolds.
Jieyun Xu   +12 more
wiley   +1 more source

Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study

open access: yesArtificial Organs, Volume 49, Issue 5, Page 852-863, May 2025.
The median SOFA score decreased from 10 to 4 after 7 days. Decreased circulatory and renal SOFA scores were characteristic. Granulocytes, mainly neutrophils, were adsorbed, and the neutrophil‐to‐lymphocyte ratio significantly improved. The median APACHE II score was 27, and the 28‐day mortality rate was 7.8%.
Osamu Nishida   +20 more
wiley   +1 more source

Increased packed cell volume alters point of care viscoelastic clotting parameters in horses

open access: yesEquine Veterinary Journal, Volume 57, Issue 3, Page 766-773, May 2025.
Abstract Background Polycythaemia and coagulopathy are identified risk factors for non‐survival in critically ill horses. Assessment of coagulation is recommended for critical care monitoring but may be affected by concurrent polycythaemia. Objective To evaluate the effects of induced polycythaemia on coagulation parameters as measured by a point‐of ...
Rebecca C. Bishop   +5 more
wiley   +1 more source

Filling the gaps to empower regional centres to manage myelodysplastic syndrome and acute myeloid leukaemia leading to wider cancer healthcare delivery and access to clinical trials

open access: yesInternal Medicine Journal, Volume 55, Issue 5, Page 722-727, May 2025.
Abstract Background The management of patients with haematological malignancies in rural and regional Australia is different to that in metropolitan centres due to many factors. Lower‐intensity and easier‐to‐access treatments that are now available for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) have improved the deliverability of ...
Michael Ashby   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy